Insider · CIK 0001946505
Julie Person
Files at AURA (Aura Biosciences, Inc.). First filing -, latest -.
In brief
Julie Person files SEC Form 4 as officer at AURA (Aura Biosciences, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Julie Person has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 5, 2023 | THRD THIRD HARMONIC BIO INC | 12,863 0.03% of outstanding | $122k | Dec 5, 2023 | none |
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Common Stock | +107,611 | $0.00 | $0 | 107,611 | 42 d ago |
| Sep 1, 2026 | AURA Aura Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +212,389 | $0.00 | $0 | 212,389 | 42 d ago |
Questions about Julie Person
Answered from the filings on this page, as of the latest one.
Is Julie Person buying or selling?
Julie Person has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Julie Person's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Julie Person has 0.
Where does Julie Person file Form 4?
Julie Person has filed Form 4 at AURA (Aura Biosciences, Inc.) as Chief People Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.